S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients who
have unresectable or metastatic gastrointestinal stromal tumors.